Ectomesenchymal Developmental Field Disorders: A Conceptual Framework for Combined Cutaneous Malformations

1. Introduction

Histopathological classifications are retrospective: entities are named according to the mature cells, tissues, and architecture of which they are composed. By contrast, the study of embryonic development is prospective and relational: it focuses on migratory progenitors, transient signalling centres, reciprocal tissue interactions, and regional developmental fields.

This distinction is important because some cutaneous malformations that appear heterogeneous when classified according to their mature tissues may reflect a single developmental abnormality, particularly when their different tissue components occur together in an organised anatomical pattern.

The neural crest provides a useful pathogenic model for understanding this phenomenon. Its migratory progenitors give rise to melanocytic, neural, glial, neuroendocrine, and mesenchymal cell populations restricted to specific anatomical regions. This last component (the mesenchymal component derived from the neural crest) is known as ectomesenchyme [1,2] (Figure 1).

2. Ectomesenchyme and Developmental Fields

The term ectomesenchyme denotes mesenchymal derivatives that originate from the ectoderm via the neural crest. In this process, neural crest cells undergo an epithelial-to-mesenchymal transition.[1]

This capacity is best established in the cranial neural crest, which contributes to craniofacial connective tissues, including cartilage and bone, as well as to pericytes and smooth muscle cells in vascular walls.[2] By contrast, the trunk neural crest has more restricted potential and contributes mainly to neural, glial, melanocytic, and neuroendocrine lineages. In recent years, however, the existence of trunk neural crest ectomesoderm has also been recognised.[3,4,5,6]

This information can be considered alongside the concept of a “developmental field”. A developmental field is a spatially restricted embryonic territory in which distinct progenitors and differentiating tissues are coordinated through positional information, molecular signals, and reciprocal interactions. Its components need not share a lineage or clone: their association may instead result from common exposure to morphogens, proximity during migration, or the induction of one developing tissue by another.

The relationship between blood vessels and nerve trunks, which are consistently in close anatomical proximity, provides a good example.[7,8,9] During formation of the neurovascular bundle, developing nerves and vessels interact. Sensory nerves guide the differentiation and branching of cutaneous arteries, while nerve-derived CXCL12 and vascular endothelial growth factor A (VEGF-A) contribute to establishing the pattern of vascular distribution.[7,8,9]

Ectodermal placodes provide another particularly illustrative example. Although they do not originate from the neural crest, they remain closely associated with cells migrating from the neural crest and interact with them to coordinate their migration, differentiation, and organisation[10] (Figure 2). Disruption of these interactions could affect both populations without their sharing a common clonal origin.

Developmental fields may also be affected by abnormalities. We define an ectomesenchymal developmental field disorder as a spatially organised abnormality affecting at least two tissue components whose association can plausibly be linked to neural crest-derived progenitors, ectomesenchymal derivatives, or recognised interactions between these populations and neighbouring embryonic tissues.

These interactions are crucial to understanding that, although demonstration of the same pathogenic alteration in separately isolated cellular components provides strong evidence of a shared mosaic origin, detection of a mutation in bulk tissue does not establish that all histological components carry that alteration.

3. Mechanisms of Ectomesenchymal Developmental Field Alteration

Broadly, an ectomesenchymal developmental field may be altered through three mechanisms, which may act independently or overlap: alteration of a common progenitor, an early somatic mutation distributed across populations that subsequently diverge, or disrupted signalling between genetically distinct populations. Mature morphology does not reliably identify which mechanism was involved.

3.1. Alteration of a Common Progenitor with the Capacity to Contribute to Different Tissues (Figure 3A)

A pathogenic alteration may arise before lineage segregation in a progenitor capable of contributing to multiple components. Histological heterogeneity would then reflect the divergent differentiation of an altered ancestral population.

The final phenotype would depend on the alteration, axial identity, developmental competence, migratory fate, and timing of lineage restriction.[1]

3.2. Early Somatic Mosaicism and Multilineage Phenotypes (Figure 3B)

A sufficiently early postzygotic mutation may affect more than one descendant population, giving rise to genetically distinct territories whose phenotypes reflect the distribution and developmental potential of the mutant cells.[11,12,13]

Thus, detection of the same mutation in different samples demonstrates a shared molecular event, but does not necessarily establish the existence of a single multipotent progenitor.

3.3. Disruption of Reciprocal Signalling During Development (Figure 3C)

The third mechanism requires neither a common progenitor nor a shared mutation. During development, alteration of one population may modify the migration, proliferation, survival, differentiation, or organisation of another. The resulting lesion may be developmentally integrated while remaining genetically heterogeneous.

3.4. Developmental Timing, Anatomical Territory, and Cellular Context

Developmental context modifies all three mechanisms. A mutation does not, by itself, constitute a complete morphogenetic instruction: its effects depend on when and where it arises, the competence and fate of the affected cells, and the tissues with which they interact during development.[1,11,12]

In general, earlier alterations affect broader fields and produce more heterogeneous phenotypes than later alterations, which are restricted to specific progenitors.

Regional differences in neural crest potential and local signalling may also cause the same mutation to have different effects in craniofacial and truncal territories, for example.

3.5. Overlap or Coexistence of These Mechanisms

These mechanisms may, however, coexist. The final phenotype (FP) could be represented schematically as the result of:

P = molecular alteration × developmental timing × cellular competence × anatomical territory × tissue interaction

This model therefore explains how the same alteration may produce different phenotypes in different contexts. It also explains how different genetic alterations may produce similar composite mlformations when they disrupt the same developmental relationship.

4. Relationship to Established Pathological Concepts

Although the proposed concept of ectomesenchymal developmental field alteration overlaps with established concepts in medicine (malformation, hamartoma, mosaic disorder, and síndrome), it is not synonymous with any of them. Each term describes a different dimension of disease, whereas the developmental field concept addresses the spatial and embryological relationships among its components.

A malformation is an intrinsic structural abnormality caused by disordered morphogenesis. The term identifies a developmental origin but does not necessarily explain why several tissues are affected together. By contrast, the ectomesenchymal developmental field concept describes their organisation and the relationships among them.

A hamartoma consists of a disorganised arrangement or proliferation of mature tissues normally present at the affected site. The term is primarily morphological. Describing a lesion as hamartomatous may accurately characterise its composition, but leave unexplained why its components recur together in a particular configuration.

Somatic mosaicism describes the genetic architecture: a postzygotic alteration generates genetically distinct cell populations with a segmental, patchy, or restricted distribution. The phenotype also depends on when the alteration arises, cellular competence, migration, and interactions with neighbouring tissues. However, a purely genetic interpretation does not explain why not all abnormal structures in a mosaic disorder necessarily carry the mutation. Mutant cells may alter neighbouring wild-type populations through paracrine signalling, changes in the extracellular matrix, or altered tissue mechanics. Mosaicism may therefore give rise to a developmental field, but the two terms are not synonymous.

Finally, a syndrome denotes a recurrent association of abnormalities and may guide recognition, surveillance, prognosis, or patient counselling. It does not necessarily identify the developmental mechanism linking those abnormalities. Developmental field analysis may therefore complement syndromic classification.

These terms are complementary rather than mutually exclusive. A single lesion may be a malformation, have a hamartomatous architecture, result from somatic mosaicism, and form part of a syndrome. The distinctions are clearer when each concept is considered in relation to the question it addresses:

Malformation: When, and through what general process, did the structural abnormality arise?

Hamartoma: How are the mature tissues architecturally organised?

Mosaicism: How is the molecular alteration distributed among the individual’s cells?

Syndrome: Which abnormalities recur together in the clinical setting?

Developmental field: Why are these particular tissues affected together in this specific anatomical territory?

As a limitation, the term ectomesenchymal developmental field (and, by extension, the term for abnormalities arising from such a field) should be used only when the combination can reasonably be linked to neural crest biology, ectomesenchymal differentiation, or a recognised developmental interaction between the two. As discussed above, the presence of a shared mutation constitutes strong evidence but is not essential if reciprocal signalling between genetically distinct populations is demonstrated. The defining principle is therefore coherent developmental integration, rather than uniformity of cellular origin.

5. Representative Models of Ectomesenchymal Developmental Field Disorders

Several examples in medicine provide varying degrees of evidence for the validity of this model. Some offer molecular evidence of an early mosaic event, whereas others provide embryological or morphological support.

5.1. GNAQ/GNA11-Associated Lesions

Activating mutations in GNAQ and GNA11 recur in various vascular and melanocytic lesions [1] For example, somatic GNAQ mutations cause sporadic capillary malformations and Sturge–Weber syndrome, while alterations in GNAQ or GNA11 have been reported in blue naevi and uveal melanocytic tumours.[14,15,16]

Phakomatosis pigmentovascularis is particularly illustrative because vascular and melanocytic abnormalities coexist regionally, and mosaic GNAQ or GNA11 mutations have been demonstrated in affected tissues. [11]

5.2. PIK3CA-Related Overgrowth

PIK3CA-related overgrowth disorders combine regional vascular malformations, adipose or fibrous overgrowth, cutaneous changes, and skeletal or muscular abnormalities. Activating PIK3CA variants are somatic and mosaic; in some cases, the mutation is detectable only at low levels in affected tissue.[12]

CLOVES syndrome and facial infiltrating lipomatosis illustrate how a single postzygotic event can affect tissue compartments conventionally regarded as distinct. In facial infiltrating lipomatosis, PIK3CA mutations have been demonstrated in several affected tissues.[13] These disorders show that early mosaicism can give rise to regional phenotypes with multiple components.

At present, although there is no strong evidence that PIK3CA-related overgrowth disorders are intrinsically ectomesenchymal in humans, murine models demonstrate that neural crest cells can contribute to the formation of cranial adipocytes and fibro-adipogenic progenitors.[17]

5.3. Vasculoneural Integration: Plexiform Neurofibroma

Vasculoneural integration provides a distinct model, based on a recognised embryonic interaction rather than a demonstrated shared mutation. As discussed above, during cutaneous development, sensory nerves influence vascular branching and arterial differentiation through coordinated trophic and guidance signals.[8,9]

Plexiform neurofibromas contain neoplastic cells of the Schwann cell lineage, together with fibroblastic populations, mast cells, perineurial-like cells, vascular populations, and other stromal components.[18]

In our dermatopathology practice, however, we have observed examples of plexiform neurofibromas with an unusually prominent vascular component and complex architecture. In these cases, the vessels appear integrated with expanded neural structures, sometimes producing a combined vasculoneural architecture with conspicuous mural features (Figure 4 and Figure 5).

This morphology does not demonstrate common clonality. Alternatively, abnormal Schwann cell lineage or stromal populations could influence vascular differentiation through pathways related to embryonic neurovascular patterning (Figure 6). Single-nucleus and spatial studies have already demonstrated the cellular complexity and intercellular communication anticipated in plexiform neurofibromas.[18]

5.4. Placodal Interactions

The neural crest and ectodermal placodes have distinct origins but interact during the formation of cranial sensory structures [10] (Figure 2). An alteration primarily affecting one of these populations could therefore modify the migration or differentiation of the other, even in the absence of a shared ancestral origin or identical mutation.

5.5. Continuum of Evidence

These examples provide evidence of varying strength. GNAQ/GNA11-associated pigmentovascular phenotypes demonstrate a molecular link. PIK3CA-related overgrowth establishes the presence of regional mosaicism with multiple components. Placodal biology illustrates the integration of distinct lineages. Finally, certain plexiform neurofibromas provide a morphological observation consistent with a probable mechanism of reciprocal signalling.

6. Testable Levels of Evidence

6.1. Level I: Anatomical Coexistence

The presence of two or more abnormalities within the same lesion or region identifies a possible composite lesion, but provides weak evidence of a developmental relationship.

The components may coexist by chance or as a consequence of inflammation, hypoxia, angiogenesis, stromal recruitment, or remodelling. At this level, no inference regarding common origin, mosaicism, or developmental interaction is justified.

6.2. Level II: Reproducible Topographical Integration

Evidence is stronger when the components show a reproducible, non-random spatial relationship: for example, when vessels repeatedly follow abnormal nerves, or when pigmentary and vascular abnormalities occupy corresponding territories.

This organisation suggests a shared pattern but does not distinguish between a shared lineage, reciprocal induction, or secondary recruitment. A relationship to a developmental field may be suspected, but cannot be established.

6.3. Level III: Correspondence with a Recognised Embryonic Interaction

Biological plausibility increases when the architecture recapitulates a recognised embryonic relationship, such as neurovascular interactions or interactions between the neural crest and placodes.[8,9,10] However, developmental interdependence does not in itself imply common clonality.

6.4. Level IV: Concordant Molecular Alteration in Separately Analysed Components

Confidence increases substantially when the same pathogenic alteration is identified in separately analysed components. Bulk-tissue sequencing is insufficient because it does not localise the mutant cells.

Morphologically distinct populations should therefore be isolated by microdissection, cell separation, or another method capable of resolving the different compartments. The presence of concordant variants supports a shared mosaic event. Differences in variant allele frequency may reflect unequal proportions of mutant cells or admixture with wild-type cells.

Even in this setting, molecular concordance provides stronger evidence for a shared early event than for a precise lineage tree, because the mutation may have arisen before several lineages separated.

6.5. Level V: Molecular and Functional Evidence

The strongest evidence combines molecular findings with identification of the relevant cells and, ideally, functional evidence of their interaction.

Single-cell or single-nucleus sequencing, spatial transcriptomics, high-resolution genotyping, and related techniques can localise variants and signalling interfaces. These methods can distinguish between an alteration shared by differentiated populations and a mutation restricted to one population that reorganises an adjacent wild-type compartment.[19]

7. Limitations of the Model

Neural crest contribution to mesenchyme is extensive in craniofacial territories but more restricted in other regions. Therefore, vascular, adipocytic, or fibrous components do not, by themselves, establish a neural crest origin, since the origins of endothelial, mural, and stromal cells vary according to anatomical location.[2] Accordingly, the adjective ectomesenchymal is justified only when neural crest-derived populations, their mesenchymal derivatives, or recognised interactions involving these components are central to the proposed relationship.

Spatial organisation does not, in itself, establish developmental causality. Tumours recruit vessels, nerves influence the stroma, and inflammation and mechanical forces remodel tissues.

Molecular concordance may also be overinterpreted. A shared variant supports the existence of a common early event, but bulk-tissue sequencing cannot identify which cells carry it; moreover, even concordance between compartments does not demonstrate that they arose from the same immediate multipotent progenitor. Conversely, a variant restricted to one population may reorganise neighbouring wild-type populations. A shared mutation, a shared lineage, and a shared developmental field are related concepts, but they are not equivalent. Future studies should prioritise microdissection, single-cell or single-nucleus methods, and spatial genomics or transcriptomics that preserve cellular and topographical information.[19]

8. Implications

Developmental history may provide an intermediate level of explanation between genotype and mature phenotype. A mutation acts in cells with a particular developmental competence, at a specific time and place, and in the presence of neighbouring populations capable of responding.

This context may explain how the same molecular alteration gives rise to different phenotypes, and how different alterations converge on a similar composite morphology. Neither genotype nor mature morphology alone necessarily captures the full developmental history of a lesion.

9. Conclusion

Ectomesenchymal developmental field disorders provide a cautious framework for interpreting selected regional abnormalities in which neural crest-derived populations, ectomesenchymal derivatives, and neighbouring tissues that interact during development are affected in a coordinated manner. Common progenitors, early mosaicism, and reciprocal signalling are complementary mechanisms, but none can be inferred from morphological coexistence alone.